Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1981 Sep;135(3):191–200.

Modern Neurosyphilis: A Partially Treated Chronic Meningitis

John R Hotson 1,2
PMCID: PMC1273113  PMID: 7340118

Abstract

Approximately 5,000 new cases of neurosyphilis may occur in the United States each year. General paresis and tabes dorsalis, however, have become relatively rare since the introduction of penicillin. Seizures, neuro-ophthalmologic symptoms, stroke and acute meningoencephalitis are currently the most common manifestations of neurosyphilis.

In more than a third of patients with neurosyphilis, nontreponemal tests for syphilis (such as VDRL) are negative and should not be used to exclude the diagnosis. Specific treponemal tests are more sensitive and more specific. Examination of the cerebrospinal fluid may show no abnormalities in neurosyphilis and is not an infallible guide to the activity of the infection.

Penicillin is the only proven antibiotic treatment of neurosyphilis. However, low-dose regimens do not produce spirocheticidal concentrations in the brain, and high-dose penicillin therapy is recommended to insure eradication of the spirochetes. Doxycycline, a tetracycline derivation that achieves relatively high concentration in the brain, may also be effective.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balkany T. J., Dans P. E. Reversible sudden deafness in early acquired syphilis. Arch Otolaryngol. 1978 Feb;104(2):66–68. doi: 10.1001/archotol.1978.00790020008002. [DOI] [PubMed] [Google Scholar]
  2. Barza M., Brown R. B., Shanks C., Gamble C., Weinstein L. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother. 1975 Dec;8(6):713–720. doi: 10.1128/aac.8.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryceson A. D. Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis. 1976 Jun;133(6):696–704. doi: 10.1093/infdis/133.6.696. [DOI] [PubMed] [Google Scholar]
  4. Catterall R. D. Neurosyphilis. Br J Hosp Med. 1977 Jun;17(6):585–604. [PubMed] [Google Scholar]
  5. Catterall R. D. Presidential Address to the M.S.S.V.D. Systemic disease and the biological false positive reaction. Br J Vener Dis. 1972 Feb;48(1):1–12. doi: 10.1136/sti.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dunlop E. M., Al-Egaily S. S., Houang E. T. Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA. 1979 Jun 8;241(23):2538–2540. [PubMed] [Google Scholar]
  7. Dunlop E. M. Persistence of treponemes after treatment. Br Med J. 1972 Jun 3;2(5813):577–580. doi: 10.1136/bmj.2.5813.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ekbom K. Carbamazepine in the treatment of tabetic lightning pains. Arch Neurol. 1972 Apr;26(4):374–378. doi: 10.1001/archneur.1972.00490100104012. [DOI] [PubMed] [Google Scholar]
  9. Felton W. F. Estimate of annual incidence of undiscovered syphilis. Br J Vener Dis. 1973 Jun;49(3):249–255. doi: 10.1136/sti.49.3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fisher C. M. Some neuro-ophthalmological observations. J Neurol Neurosurg Psychiatry. 1967 Oct;30(5):383–392. doi: 10.1136/jnnp.30.5.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fisher M., Poser C. M. Syphilitic meningomyelitis. A case report. Arch Neurol. 1977 Dec;34(12):785–785. doi: 10.1001/archneur.1977.00500240073015. [DOI] [PubMed] [Google Scholar]
  12. Giménez-Roldán S., Benito C., Martin M. Dementia paralytica: deterioration from communicating hydrocephalus. J Neurol Neurosurg Psychiatry. 1979 Jun;42(6):501–508. doi: 10.1136/jnnp.42.6.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Godt P., Stoeppler L., Wischer U., Schroeder H. H. The value of computed tomography in cerebral syphilis. Neuroradiology. 1979 Oct 31;18(4):197–200. doi: 10.1007/BF00345725. [DOI] [PubMed] [Google Scholar]
  14. Goldman J. N., Lantz M. A. FTA-ABS and VDRL slide test reactivity in a population of nuns. JAMA. 1971 Jul 5;217(1):53–55. [PubMed] [Google Scholar]
  15. HAHN R. D. Some remarks on the management of neurosyphilis. J Chronic Dis. 1961 Jan;13:1–5. doi: 10.1016/0021-9681(61)90040-6. [DOI] [PubMed] [Google Scholar]
  16. HUNTER E. F., DEACON W. E., MEYER P. E. AN IMPROVED FTA TEST FOR SYPHILIS, THE ABSORPTION PROCEDURE (FTA-ABS). Public Health Rep. 1964 May;79:410–412. [PMC free article] [PubMed] [Google Scholar]
  17. Harner R. E., Smith J. L., Israel C. W. The FTA-ABS test in late syphilis. A serological study in 1,985 cases. JAMA. 1968 Feb 19;203(8):545–548. [PubMed] [Google Scholar]
  18. Heathfield K. W. The decline of neurolues. Practitioner. 1976 Nov;217(1301):753–762. [PubMed] [Google Scholar]
  19. Hooshmand H., Escobar M. R., Kopf S. W. Neurosyphilis. A study of 241 patients. JAMA. 1972 Feb;219(6):726–729. doi: 10.1001/jama.219.6.726. [DOI] [PubMed] [Google Scholar]
  20. Jaffe H. W., Larsen S. A., Peters M., Jove D. F., Lopez B., Schroeter A. L. Tests for treponemal antibody in CSF. Arch Intern Med. 1978 Feb;138(2):252–255. [PubMed] [Google Scholar]
  21. Joffe R., Black M. M., Floyd M. Changing clinical picture of neurosyphilis: report of seven unusual cases. Br Med J. 1968 Jan 27;1(5586):211–212. doi: 10.1136/bmj.1.5586.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. John J. F., Jr, Cuetter A. C. Spinal syphilis: the problem of fluorescent treponemal antibody in the cerebrospinal fluid. South Med J. 1977 Mar;70(3):309–311. [PubMed] [Google Scholar]
  23. Jordan K., Marino J., Damast M. Bilateral oculomotor paralysis due to neurosyphilis. Ann Neurol. 1978 Jan;3(1):90–93. doi: 10.1002/ana.410030114. [DOI] [PubMed] [Google Scholar]
  24. Joyce-Clarke N., Molteno A. C. Modified neurosyphilis in the Cape Peninsula. S Afr Med J. 1978 Jan 7;53(1):10–14. [PubMed] [Google Scholar]
  25. KOFMAN O. The changing pattern of neurosyphilis. Can Med Assoc J. 1956 May 15;74(10):807–812. [PMC free article] [PubMed] [Google Scholar]
  26. Luxon L., Lees A. J., Greenwood R. J. Neurosyphilis today. Lancet. 1979 Jan;1(8107):90–93. doi: 10.1016/s0140-6736(79)90074-6. [DOI] [PubMed] [Google Scholar]
  27. Mohr J. A., Griffiths W., Jackson R., Saadah H., Bird P., Riddle J. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA. 1976 Nov 8;236(19):2208–2209. [PubMed] [Google Scholar]
  28. Onoda Y. Therapeutic effect of oral doxycycline on syphilis. Br J Vener Dis. 1979 Apr;55(2):110–115. doi: 10.1136/sti.55.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rothenberg R. Treatment of neurosyphilis. J Am Vener Dis Assoc. 1976 Dec;3(2 Pt 2):153–158. [PubMed] [Google Scholar]
  30. Rudolph A. H. The microhemagglutination assay for Treponema pallidum antibodies (MHA-TP), a new treponemal test for syphilis: where does it fit? J Am Vener Dis Assoc. 1976 Sep;3(1):3–8. [PubMed] [Google Scholar]
  31. SEGAL P., JANISZEWSKA-GELDNER B., LEONOWICZ-MICHNIOWSKA J. Results of penicillin therapy in syphilitic primary optic atrophy. Br J Vener Dis. 1960 Dec;36:257–260. doi: 10.1136/sti.36.4.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sparling P. F. Diagnosis and treatment of syphilis. N Engl J Med. 1971 Mar 25;284(12):642–653. doi: 10.1056/NEJM197103252841205. [DOI] [PubMed] [Google Scholar]
  33. Tomecki K. J., Plaut M. E. Syphilis surveillance. Failure to screen in a university hospital. JAMA. 1976 Dec 6;236(23):2641–2642. doi: 10.1001/jama.236.23.2641. [DOI] [PubMed] [Google Scholar]
  34. Tramont E. C. Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA. 1976 Nov 8;236(19):2206–2207. [PubMed] [Google Scholar]
  35. WETHERILL J. H., WEBB H. E., CATTERALL R. D. SYPHILIS PRESENTING AS AN ACUTE NEUROLOGICAL ILLNESS. Br Med J. 1965 May 1;1(5443):1157–1158. doi: 10.1136/bmj.1.5443.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yoder F. W. Penicillin treatment of neurosyphilis. Are recommended dosages sufficient? JAMA. 1975 Apr 21;232(3):270–271. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES